Examinando por Autor "Polentinos-Castro , Elena"

Mostrando 1 - 2 de 2

Health condition and risk attitude in the Dutch population: an exploratory approach
(Taylor & Francis, 2018-03-30) Martín Fernández, Jesús; Medina-Palomino, Héctor; Ariza-Cardiel, Gloria; Polentinos-Castro , Elena; Rutkowski, Anne
Abstract Risk is a central aspect of health condition because attitudes towards risk may influence the inclination to adopt behaviours that can influence health condition. Taking preventive health care measures or purchasing a private health insurance are examples of decisions individuals make based on their preferences. This study analysed the relationship between health condition and behaviour under conditions of uncertainty and examined personal characteristics related to risk behaviour. Data was obtained from a survey on a representative sample of the Dutch adult population (n = 2,822) conducted between May and June of 2014. Risk attitude was assessed through a self-reported scale and risk behaviours through a simulated lottery game, both included in the same survey. The relationship between risk attitudes and behaviours was examined, as well as certain socio-economic variables, including health condition, demographic characteristics, social status, and confidence in government institutions. Surveyed participants perceived themselves as risk-avoiding. However, their behaviour tended to be risk-seeking when playing lottery games, even when they faced potential (but limited) economic losses. Participants with poorer mental health condition tended to be less risk-inclined, which was not the case for participants who reported poor general health status. Participants feeling a higher satisfaction with their lives were willing to take greater risks in the lottery games. These findings allow for understanding risk behaviour as the interaction between personal perception of risk attitude and the assessment of risk associated to a specific situation. This assessment may be directly modulated by one’s state of mind and not by physical health condition.
How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention.
(MDPI, 2022-05-06) del Cura-González, Isabel; López-Rodríguez, Juan Antonio; López-Verde, Fernando; Lozano-Hernández, Cristina; Pico-Soler., Victoria; Bujalance-Zafra , Maria Jose; Gimeno-Feliu, Luis; Aza-Pascual-Salcedo , Mercedes; Rogero-Blanco , Marisa; González-Rubio , Francisca; García-de-Blas , Francisca; Polentinos-Castro , Elena; Sanz-Cuesta , Teresa; Castillo-Jimena, Marcos; Alonso-García , Mario; Calderón-Larrañaga , Amaia; Valderas , Jose Maria; Marengoni , Alexandra; Muth , Chirstiane; Prados-Torres , Juan Daniel; Prados-Torres , Alesandra
(1) Purpose: To investigate a complex MULTIPAP intervention that implements the Ariadne principles in a primary care population of young-elderly patients with multimorbidity and polypharmacy and to evaluate its effectiveness for improving the appropriateness of prescriptions. (2) Methods: A pragmatic cluster-randomized clinical trial was conducted involving 38 family practices in Spain. Patients aged 65-74 years with multimorbidity and polypharmacy were recruited. Family physicians (FPs) were randomly allocated to continue usual care or to provide the MULTIPAP intervention based on the Ariadne principles with two components: FP training (eMULTIPAP) and FP patient interviews. The primary outcome was the appropriateness of prescribing, measured as the between-group difference in the mean Medication Appropriateness Index (MAI) score change from the baseline to the 6-month follow-up. The secondary outcomes were quality of life (EQ-5D-5 L), patient perceptions of shared decision making (collaboRATE), use of health services, treatment adherence, and incidence of drug adverse events (all at 1 year), using multi-level regression models, with FP as a random effect. (3) Results: We recruited 117 FPs and 593 of their patients. In the intention-to-treat analysis, the between-group difference for the mean MAI score change after a 6-month follow-up was -2.42 (95% CI from -4.27 to -0.59) and, between baseline and a 12-month follow-up was -3.40 (95% CI from -5.45 to -1.34). There were no significant differences in any other secondary outcomes. (4) Conclusions: The MULTIPAP intervention improved medication appropriateness sustainably over the follow-up time. The small magnitude of the effect, however, advises caution in the interpretation of the results given the paucity of evidence for the clinical benefit of the observed change in the MA